INHIBITION OF ENDOTOXIN-INDUCED ACTIVATION OF HUMAN-MONOCYTES BY HUMAN LIPOPROTEINS
INHIBITION OF ENDOTOXIN-INDUCED ACTIVATION OF HUMAN-MONOCYTES BY HUMAN LIPOPROTEINS
复制标题
DOI:
10.1128/iai.57.7.2237-2245.1989
复制
发表时间:
1989-07-01
影响因子:
3.1
通讯作者:
NORTHOFF, H
中科院分区:
文献类型:
--
作者:
FLEGEL, WA;WOLPL, A;NORTHOFF, H
Toxicity of lipopolysaccharide (LPS) (endotoxin) is, to a large extent, mediated by the activation of monocytes/macrophages and subsequent release of monokines, such as interleukin-1 (IL-1) and tumor necrosis factor alpha (TNF-.alpha.). It is known that LPS binds readily to serum lipoproteins and that LPS-lipoprotein complexes are less toxic than unbound LPS. Here we present data analyzing the impact of the LPS-serum interaction at the cellular level. by measuring IL-1 TNF-.alpha., and IL-6, the interaction of different LPSs or lipid A with human serum could be shown to prevent the activation of human monocytes. The amounts of LPS inactivated by normal human serum did not exceed 10 ng/ml. The LPS-inactivating capacity of serum was shown to be a function of the lipoproteins. Other serum components, such as naturally occurring anti-LPS immunoglobulin G, complement, or nutritive lipids, had no significant influence in our system. Our experiments suggest that serum lipoproteins control endotoxin-induced monocyte activation and monokine release.